Arcturus isn't going to file for US FDA approval for their #covid #COVID19 self-amplifying mRNA vaccine. From their CFO Andy Sassine in their third quarter results: “The sudden changes in regulatory requirements by the FDA for COVID-19 vaccines have delayed the U.S. BLA filing for KOSTAIVE® indefinitely." It has already been approved in Japan and the EU, and it is madness that we are killing off availability for this NextGen vaccine here in the US.